日本人2型糖尿病患者におけるインスリングラルギン／リキシセナチド固定比率配合剤の食後血糖動態反応

基本情報

NCT ID

NCT02713477

ステータス

完了

試験のフェーズ

第1相

試験タイプ

介入

目標被験者数

20

治験依頼者名

Sanofi

概要

Primary Objective: To assess the postprandial glucodynamic response to 2 doses of insulin glargine/lixisenatide fixed-ratio combination compared to placebo in Japanese patients with type 2 diabetes mellitus (T2DM). Secondary Objectives: * To assess the pharmacokinetics (PK) of lixisenatide following administration of 2 different doses of insulin glargine/lixisenatide fixed-ratio combination in Japanese patients with T2DM. * To assess the postprandial glucodynamic response to insulin glargine/lixisenatide fixed-ratio combination compared to insulin glargine alone in Japanese patients with T2DM. * To assess the safety and tolerability of insulin glargine/lixisenatide fixed-ratio combination in Japanese patients with T2DM.

対象疾患

介入

依頼者（Sponsor）